...
首页> 外文期刊>European journal of human genetics: EJHG >Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members.
【24h】

Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members.

机译:使用条件最大似然方法,估计通过受影响家庭成员收集的家谱中主要CARD15 / NOD2突变的克罗恩病几率。

获取原文
获取原文并翻译 | 示例
           

摘要

Estimation of genotype-specific risks at a disease susceptibility locus is an important question that is best carried out in a prospective study. Nevertheless it is usually desirable to make use of data from the families that have already been collected to identify the susceptibility locus. Assuming that the families have been collected without regard to genotype at the locus in question, most of the information can be extracted by writing the likelihood in terms of the risk for a genotype relative to the standard genotype and conditional on the parental mating type. Parameters may then be estimated by explicit solution of likelihood equations. This method permits estimation of risks for heterozygotes and homozygotes for different alleles, testing of different modes of inheritance and heterogeneity of risk between alleles. It is applicable to risk alleles for any disease locus or incompletely penetrant phenotype. We have used the method to estimate risks of Crohn disease for different CARD/NOD2 15 mutations, using the families originally collected to identify this susceptibility locus. The odds ratio of Crohn disease were, respectively, 1.97+/-0.85, 3.05+/-* and 4.55+/-1.34 for the R702W, G9068R and 1007fs heterozygotes and 3.29+/-0.64, 12.13+/-* and 34.66+/-12.87 for the corresponding homozygotes. (* Signifies insufficient data to estimate these values.) These results confirm the dosage effect for CARD15/NOD2 mutations and demonstrate that the disease risks are very different in homozygotes. This last observation illustrates the power of this approach, especially for alleles with low or moderate frequency in the general population.
机译:疾病易感性基因位点的基因型特异性风险的估计是一个重要的问题,最好在前瞻性研究中进行。然而,通常希望利用已经收集的家庭数据来确定易感性位点。假设在不考虑相关基因座的基因型的情况下收集了这些家庭,则可以通过写下相对于标准基因型的基因型风险和以父母交配类型为条件的可能性来提取大多数信息。然后可以通过似然方程的显式解来估计参数。该方法可以估计不同等位基因杂合子和纯合子的风险,测试不同的遗传模式和等位基因之间的风险异质性。它适用于任何疾病位点或不完全渗透表型的风险等位基因。我们使用了最初收集的家族来鉴定该易感性基因座的方法,以估算针对不同的CARD / NOD2 15突变的克罗恩病风险。对于R702W,G9068R和1007fs杂合子,克罗恩病的优势比分别为1.97 +/- 0.85、3.05 + /-*和4.55 +/- 1.34,以及3.29 +/- 0.64、12.13 + /-*和34.66+ /-12.87为相应的纯合子。 (*表示没有足够的数据来估计这些值。)这些结果证实了CARD15 / NOD2突变的剂量效应,并证明纯合子的疾病风险有很大差异。最后的观察结果说明了这种方法的功效,特别是对于一般人群中频率较低或中等的等位基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号